Alpine Woods Capital Investors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Other funds holding MACK
TCIM
CC
Alpine Woods Capital Investors's MACK Position: Q2 2017 in Review
Alpine Woods Capital Investors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2017, closing a stake of 92,275 shares — an estimated $2.24M sold.
Alpine Woods Capital Investors first reported a position in MACK in Q1 2017 and held it in 1 quarter. The position peaked at $2.24M in Q1 2017. 119 funds tracked by Wall St. Rank hold MACK as of Q2 2017.
- Alpine Woods Capital Investors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
- Alpine Woods Capital Investors sold 92,275 Merrimack Pharmaceuticals, Inc. shares in Q2 2017, an estimated $2.24M.
- Alpine Woods Capital Investors first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2017 and held it in 1 quarter.
- Alpine Woods Capital Investors's Merrimack Pharmaceuticals, Inc. position peaked at $2.24M in Q1 2017.
- 119 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2017.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2017, filed 2 Aug 2017.